Uni Prot Comments Displayer
Protein Atlas Displayer
Gene Expression Atlas Tissues Displayer
Gene Expression Atlas Diseases Displayer
Publication Counts Displayer
Curated Proteins Displayer
Function
Gene Ontology Displayer
31 Pathways
- Resistance of ERBB2 KD mutants to lapatinib,
- Programmed Cell Death,
- Signal Transduction,
- Drug resistance in ERBB2 TMD/JMD mutants,
- Regulation of necroptotic cell death,
- Resistance of ERBB2 KD mutants to AEE788,
- RIPK1-mediated regulated necrosis,
- Diseases of signal transduction by growth factor receptors and second messengers,
- Signaling by ERBB2,
- Constitutive Signaling by Overexpressed ERBB2,
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,
- Resistance of ERBB2 KD mutants to trastuzumab,
- Resistance of ERBB2 KD mutants to neratinib,
- Signaling by ERBB2 ECD mutants,
- Drug-mediated inhibition of ERBB2 signaling,
- Signaling by ERBB2 KD Mutants,
- Signaling by ERBB2 TMD/JMD mutants,
- Constitutive Signaling by EGFRvIII,
- Resistance of ERBB2 KD mutants to osimertinib,
- Signaling by Ligand-Responsive EGFR Variants in Cancer,
- Signaling by ERBB2 in Cancer,
- Signaling by Receptor Tyrosine Kinases,
- Regulated Necrosis,
- Disease,
- Signaling by EGFRvIII in Cancer,
- Resistance of ERBB2 KD mutants to afatinib,
- Resistance of ERBB2 KD mutants to tesevatinib,
- Downregulation of ERBB2 signaling,
- Signaling by EGFR in Cancer,
- Resistance of ERBB2 KD mutants to sapitinib,
- Drug resistance in ERBB2 KD mutants
Gene --> GO terms.
Gene -> HPO annotation (Human Phenotype Ontology)
Mouse Gene --> Allele [Phenotype]
Genomics
J Browse Displayer
Gene Structure Displayer
Overlapping Features Displayer
Mouse Alleles Displayer
Gene --> Chromosomal location.
Gene --> GO terms.
Gene --> Overlapping genes.
Disease
Gene (Hum OR Rat) --> Mouse Allele (Phenotype)
Gene --> Alleles and Disease (clinVar data)
Gene -> HPO annotation (Human Phenotype Ontology)
Mouse Gene --> Allele [Phenotype]
Other
31 Pathways
- Resistance of ERBB2 KD mutants to lapatinib,
- Programmed Cell Death,
- Signal Transduction,
- Drug resistance in ERBB2 TMD/JMD mutants,
- Regulation of necroptotic cell death,
- Resistance of ERBB2 KD mutants to AEE788,
- RIPK1-mediated regulated necrosis,
- Diseases of signal transduction by growth factor receptors and second messengers,
- Signaling by ERBB2,
- Constitutive Signaling by Overexpressed ERBB2,
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,
- Resistance of ERBB2 KD mutants to trastuzumab,
- Resistance of ERBB2 KD mutants to neratinib,
- Signaling by ERBB2 ECD mutants,
- Drug-mediated inhibition of ERBB2 signaling,
- Signaling by ERBB2 KD Mutants,
- Signaling by ERBB2 TMD/JMD mutants,
- Constitutive Signaling by EGFRvIII,
- Resistance of ERBB2 KD mutants to osimertinib,
- Signaling by Ligand-Responsive EGFR Variants in Cancer,
- Signaling by ERBB2 in Cancer,
- Signaling by Receptor Tyrosine Kinases,
- Regulated Necrosis,
- Disease,
- Signaling by EGFRvIII in Cancer,
- Resistance of ERBB2 KD mutants to afatinib,
- Resistance of ERBB2 KD mutants to tesevatinib,
- Downregulation of ERBB2 signaling,
- Signaling by EGFR in Cancer,
- Resistance of ERBB2 KD mutants to sapitinib,
- Drug resistance in ERBB2 KD mutants